Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Liposome Injection Dose Escalation in Advanced Solid Tumors
NCT01994031Phase 4Unknown
- Sponsor
- Luye Pharma Group
- Start
- Aug 2014
- Primary completion
- Jul 2015
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of liposomal paclitaxel in solid tumor, sponsored by Luye Pharma Group. Status: unknown.
02
Drugs
liposomal paclitaxel
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT01994031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01994031.